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A novel protein kinase is induced in rat liver plasma membrane by the administration of peroxisome proliferators. A 36 kDa protein (P36) on the 
membrane was rapidly phosphorylated in vitro by the kinase and the phosphorylated amino acid was identified as phosphohistidine. Histidine 
phosphorylation of P36 was activated in vitro by recombinant Ras protein and GTP; both decreased Michaelis constant (K,,,) for ATP from 1.25 
to 0.25 PM. The novel histidine kinase, products of which have been overlooked due to their acid lability, may participate in cellular signaling and 
peroxisome proliferators may perturb the pathway. 
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1. INTRODUCTION 
Peroxisomes are found in almost every eukaryotic cell 
and have diverse metabolic functions [1,2]. One of the 
most characteristic features of peroxisome biology is 
that the organelle is remarkably proliferated in response 
to structurally diverse xenobiotic agents, peroxisome 
proliferators [3]. Recent studies on a peroxisome prolif- 
erator receptor proposed a steroid hormone-like recep- 
tor-mediated mechanism for the transcriptional activa- 
tion of several genes [4,5]. Remarkable information has 
also been learned about the targeting signal [6], per- 
oxisomal assembly factors [7,8], and the cause of per- 
oxisome-deficient Zellweger syndrome [9], whereas the 
mechanism for hepatomegaly and hepatocarcinogenesis 
caused by several of the non-genotoxic proliferators in 
rodent species has not been elucidated. Reddy and co- 
workers hypothesized that the main cause for carcino- 
genesis may be a leakage of excess oxidase-producing 
H202 from peroxisomes [lo]. However, a definitive as- 
sociation between HzOz leakage caused by peroxisome 
proliferation and hepatocarcinogenesis has not been 
demonstrated. We have been i terested in the possibility 
that these agents may affect not only peroxisome-re- 
lated cellular events but also other basic and/or liver- 
specific cellular functions unrelated to peroxisomes. 
Several such changes were found, including induction 
of elongation factor 2 of protein synthesis (K. Motojima 
et al., submitted) and down-regulation of BiP/GRP78 
[I I] and transthyretin [12]. 
2. MATERIALS AND METHODS 
2.1. Animals and subcelhdar fraetionarion 
Male Fischer F-344 rats were fed a control diet (CE7, Clea Japan) 
or a diet containing 0.5% clofibrate. After 2 weeks, rats were kitled and 
the livers were minced well with scissors, homogenized in 5 ~01s. of 
sucrose buffer (0.25 M sucrose, I mM EDTA, 10% ethanol, pH 7.4) 
by a Potter-Elvehjem homogenizer, and the homogenates were centri- 
fuged for 5 min at 600 x g. The supernatant was centrifuged for 13 min 
at 2,000 x g to obtain post-mitochondrial supernatant (PMS) and the 
pellets. From the pellets, plasma membranes (PM) were purified ac- 
cording to the method of Hubbard et al. 114. 
2.2. In vitro ph~sphory~at~on 
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Abbreviations: P36, a 36 kDa protein from rat liver; PMS, post-mito- 
chondrial supernatant; PM, plasma membrane; PIPES, piperazine-N, 
K-bis(2-ethanesulfonic acid); SDS-PAGE, SDS-polyacrylamide gel 
electrophoresis; TLC, thin layer chromatography; EGF, epidermal 
growth factor. 
Phospho~lation in subcellular fractions from livers of rats were 
assayed in kination butler [14] (50 mM PIPES, pH 7.0, 0.1% Triton 
X-100, 1 mM MnCl,, 2 mM MgCl,, 10 PM sodium orthovanadate, 
2 mM sodium fluoride, and 20 mM sodium moiybdate] for phospho- 
rylation in the presence of EGF (1 pg/ml). 10 yM Okadaic acid was 
also included in some experiments. The reactions were started by the 
addition of 1 PM (final concentration) [r-“P]ATP, and were termi- 
nated by adding two ~01s. of SDS-PAGE sample buffer (2% SDS, 8 
M urea, 5% 2-mercaptoethanol, 125 mM Tris-HCl, pH 68). The 
phospho~lat~ proteins were analyzed by SDS-PAGE. The gels were 
fixed with 40% methanol and 3.7% fo~aldehyde, treated with alkali 
(t N NaOH at SOY for 1 h), dried and autoradiographed. 
2.3. Identification of phosphorytated amino acid residues 
For identification of phosphorylated amino acids in P36, 32P- 
phosphorylated proteins in the PM fraction were separated by SDS- 
PAGE and transferred to an Immobilon filter (Millipore). One filter 
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was cut into strips and incubated at 50°C m 1 N NaOH or in 7% acetic 
acid (pH 2.2) for various periods to study the time-course of hydrol- 
ysis of phosphorylated residues in proteins. For phosphoamino acid 
analysis by thin-layer chromatography (TLC), ‘?P-labeled P36 on an 
Immobilon filter was hydrolyzed in 2 N KOH at 105°C for 5 h. A 
portion of the hydrolysate was mixed with standard phosphoamino 
acids (phosphohistidine and phospholysine were synthesized as de- 
scribed [IS] and others were obtained from Sigma) directly on a silica 
gel TLC plate (Merck) with two successive solvent (ethanol :25% 
ammonia solution, 3.5 : 1.6) cycles f16]. 
Normal Induced 
2.4. Quantitatcon of radioactmitJ 
The amounts of “P radioactivities were quantitated using a 
BAS2000 image analyzer (Fuji Film, Japan) for data acquisition and 
Bioimage (Millipore) data analyses. Autoradiograms on X-ray films 
were taken only for representative pittures. 
2.5. Rero~b~na~t Ras protein and mm-Rm antibody 
The recombinant EC ras (normal human c-Ha-ras-1) expressed in 
Escherichia coli and purified to homogeneity was the generous gift 
from J.B. Gibbs of Merck Sharp 81 Dohme Research Laboratories. 
TuMark monoclonal antibodies against I”US p21 (pan) was obtained 
from NEN. 
3. RESULTS 
3.1. Induction of P36 phosphor~~lation by clofibrate 
To assess the effects of peroxisome proliferators on 
cellular signaling, we studied the in vitro phosphoryla- 
tion and dephosphorylation of endogenous proteins in 
subcellular fractions of liver. PMS fractions were used 
in the assay because they gave the most reproducible 
results under our conditions. A high level of auto- 
phosphorylation of the epidermal growth factor (EGF) 
receptor was also observed in these fractions and used 
as an internal control of in vitro phosphorylation. Ap- 
parently no proteins other than the receptor were 
phosphorylated in an EGF-dependent manner under 
the conditions used. 
Fig. 1. In vitro phosphorylation of endogenous proteins in rat liver 
PMS fractions. Phosphorylation in PMS fractions from livers of con- 
trol (Normal) and ciofibrate (0.5%)-fed (Induced) (for 2 weeks) rats 
were assayed for phospho~lation in the presence of EGF (1 &ml). 
The phosphorylated proteins were analyzed by SDS-PAGE (10%). 
The gels were fixed with 40% methanol and 3.7% formaldehyde. 
treated with alkah (1 N NaOH at 50°C for I h), dried and auto- 
ined effects of protein kinase inhibitors. The inhibitors 
and concentrations used were H-7 at 20 PM, H-S at 5 
PM, and ML-7 at 5 FM to inhibit protein kinase C, 
cyclic nucleotide-dependent protein kinase, and myosin 
light chain kinase, respectively [17,181. None inhibited 
the reaction, suggesting that P36 is not phosphorylated 
by these kinases. 
Feeding rats with a peroxisome proliferator, clofi- 
brate, for 2 weeks induced hepatomegaly (nearly 2-fold 
weight) and proliferation of peroxisomes (more than 
20-fold as assessed by the amounts of proliferation- 
associated enoyl-coenzyme A hydratase-dehydrogenase 
in PMS fractions). The pattern of phosphorylated pro- 
teins in PMS fractions changed when clofibrate was fed 
to old rats (27 month old) (Fig. 1). Phosphorylation of 
a protein having a molecular weight of 36 kDa (P36) 
was remarkably increased but the bands were detected 
only on those gels without acid treatment, such as oc- 
curs with destaining with acetic acid (see below). In 
addition to P36, phosphorylation of a protein of 100 
kDa (PlOO) was also increased in young rats (5 month 
old) fed clofibrate (not shown; K. Motojima et al., sub- 
mitted). In vitro phosphorylation of P36 was also en- 
hanced in PMS fractions from rats administered other 
types of proliferators like bezafibrate and di(2-eth- 
ylhexyl)phthaiate (not shown). 
3.2. Churacterization of P36 phosphorylation 
To characterize P36 phosphorylation, we first exam- 
Next, we analyzed the 32P linkage to P36. It was as 
resistant in alkali as that in the EGF receptor in which 
tyrosine residues were phosphorylated. Acid hydrolysis 
of [32P]P36 in 6 N HCl for 3 h at 100°C to identify the 
phosphorylated residues removed all “P from P36 and 
no P-Thr. P-Ser or P-Tyr was detected. A time-course 
study of the hydrolysis showed that the linkage of 
[32P]P36 is resistant to alkali but labile even to mild acid 
(Fig. 2A). The first order rate constant for [32P]P36 
hydrolysis at 50°C in 7% acetic acid (about pH 2.2) was 
0.03 1 min-“. These results strongly suggest the 
phosphorylated residue in P36 is phosphohistidine. 
Similar values have been reported for the hydrolysis of 
3-phosphohistidine in phospho-Enzyme I of the PTS 
(0.025 min-‘) [19] and in phospho-CheA (0.021 min-‘) 
[20] under similar conditions. To confirm that the 
phosphoamino acid in P36 is phosphohistidine, [3’P]P36 
was alkali hydrolyzed and the products were analyzed 
by TLC (Fig. 2B). Most of the 32P stayed at the origin, 
probably as inorganic phosphate liberated under the 
conditions employed, but a significant amount of 
phosphoamino acid co-migrated with the standard 
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Fig. 2. Identification of the phosphorylated amino acid residues in 
P36. (A) Time-course of hydrolysis of phosphorylated amino acids in 
proteins, P36 and P17 (control) on lmmobilon filter strips under alka- 
line or acidic conditions. The control amounts on the untreated strips 
were taken as 100 and relative amounts are shown. (B) Phosphoamino 
acid analysis by TLC. 32P-labeled P36 was transferred to an Immo- 
bilon filter and hydrolyzed in 2 N KOH at 105°C for 5 h. A portion 
of the hydrolysate was mixed with standard phosphoamino acids and 
analyzed irectly on a stlica gel TLC plate (Merck) with two successive 
solvent (ethanol:25% ammonia solution, 351.6) cycles. A BAS2000 
image of the plate is shown, as are the migrations of the standard 
phosphoamino acids. 
phosphohistidine. Phospholysine migrated faster than 
phosphoarginine on the plate under our conditions (not 
shown). Thus the novel kinase induced by peroxisome 
proliferators in rat liver phosphorylates P36 at histidine 
residue(s). 
and guanine nucleotides 
Hedge and Das [2 1,221 reported a similar protein in 
rat liver plasma membrane having a molecular weight 
of 38 kDa (P38), although they suggested that phospho- 
rylation in P38 is probably not on histidine, as they had 
thought earlier [21], but on an acyl moiety [22]. More 
interestingly, they showed enhancement of P38 phos- 
phorylation by p21 ras and GDP in vitro. To learn 
whether our P36 and their P38 were identical and, if so, 
to confirm the activation, we carried out kinetic studies 
of P36 phosphorylation with Ras protein, GTP, or 
GDP using PM fractions (see below) at O’C. The Km of 
the kinase for ATP was estimated as 1.25 ,uM (Fig. 3); 
this is significantly lower than that of recently purified 
yeast histidine kinase (60 PM) [23] and may explain the 
efficient incorporation of 32P into P36 under the condi- 
tions used in which the concentration of ATP was 1 ,uM. 
Upon addition of the saturable level of Ras protein, 
there was a large enhancement of P36 phosphorylation 
and the affinity of the kinase for ATP increased to a K,,, 
value of 0.25 ,uM. Essentially the same enhancement 
was obtained by addition of 1 ,uM GTP. In both cases 
there was also inhibition of the phosphorylation at high 
concentrations of ATP. In contrast, 1 ,uM GDP acti- 
vated the phosphorylation without changing the affinity 
for the substrate. In these assays, we preincubated PM 
fractions with these activators for 60 min on ice. During 
preincubation, the GDP-bound Ras might have con- 
verted to the GTP-bound active Ras, probably by a 
GDP/GTP exchange reaction [24]. Added GTP could 
have promoted the exchange in endogenous Ras pro- 
tein. This would explain how the addition of Ras pro- 
tein and GTP to PM fractions could have exerted the 
same type of activation, whereas excess GDP might 
have prevented the exchange and the GDP-bound en- 
dogenous Ras activated P36 phosphorylation without 
changing the affinity for ATP. Phosphorylation reac- 
tions using PM fractions, however, can be affected by 
various modulating protein factors and there are many 
other possibile explanations of the present data. Resolu- 
tion of these questions will require purification of the 
kinase and its substrate, P36, and the use of specific 
inhibitors. Although the mechanism of the activation is 
not yet known, an intimate, if not direct, interaction 
between Ras and the kinase was suggested by the kinetic 
analysis, and a possible role of Ras protein in P36 phos- 
phorylation may be the switching of the affinity of the 
kinase for ATP. 
3.4. Dephosphorylation of [32P]P36 
With PMS fractions, P36 was very rapidly 
phosphorylated with maximum values at 15 s at 0°C 
and at 30 s at 20°C followed by immediate 
dephosphorylation especially at 20°C even though the 
reaction mixture contained phosphatase inhibitors (10 
PM sodium vanadate, 2 mM sodium fluoride, and 20 
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Fig. 3. Lineweaver-Burk plot of P36 phosphorylation kinetics and 
effects of Ras protein and guanine nucleotides. PM fractions (1 mg 
protein/ml) were preincubated in kination buffer with Ras protein (50 
@ml), GTP (1 PM), GDP (1 PM) or none for I h on ice. P36 
phosphorylation in PM fractions with various concentrations of ATP 
(adjusted with cold ATP) was carried out at 0°C for 60 s. The 
phosphorylated proteins were separated by SDS-PAGE and amounts 
of phosphorylated P36 were quantitated using BAS2000 and Bioimage 
(A). Representative autoradiograms on X-ray films are shown in (B). 
mM sodium molybdate). Rapid dephosphorylation was 
also not inhibited by 10 PM okadaic acid. With PM 
fractions, however, only a relatively slow phosphoryla- 
tion was observed at either temperature, suggesting that 
P36 and its kinase, which is not necessarily different 
from P36, are located in the plasma membrane, and that 
some modulating factor(s), such as a phosphatase or a 
transferase, is present in the cytoplasm. 
4. DISCUSSION 
Our studies seem to point to the histidine phosphoryl- 
ation of P36 possibly being involved in a cellular signal- 
ing pathway in a novel manner, probably downstream 
of Ras. The reasons that the histidine phosphorylation 
has been overlooked could be its transient linkage, as 
suggested by our in vitro study, and acid lability of the 
linkage between histidine and phosphate. In bacteria, a 
signal transduction mechanism including histidine 
phosphorylation and transfer of the phosphoryl group 
to an aspartic acid side chain, followed by 
dephosphorylation by associated phosphatase activities 
has been demonstrated in several systems (for review see 
[25]). Interestingly, Huang et al. reported purification of 
a protein histidine kinase from yeast [23]; the presence 
of protein phosphohistidine in regenerating rat liver has 
also been reported [26]. Thus a similar mechanism in- 
cluding histidine phosphorylation may be operating in 
eukaryotic cells, and P36 and its kinase may be involved 
in the pathway. 
Peroxisome proliferators changed the level of P36 
phosphorylation activity in rat livers. Immunoblot anal- 
ysis using anti-H-ras monoclonal antibody (against ras 
p2l(pan); NEN) revealed that the level of Ras protein 
in PMS fractions did not change significantly during 
induction of peroxisome proliferation (not shown); so 
the level of the histidine kinase, its substrate P36, or 
another modulating factor(s) is thought to change in 
response to a proliferator. The function of P36 and its 
kinase is not known at present but such change could 
be the cause of perturbation of cellular signaling. Fur- 
ther in vitro and in vivo characterization of the kinase 
is obviously necessary and is in progress in our labora- 
tory, both to elucidate its role in signal transduction and 
pursuant to our interest in the possibility that prolifera- 
tor perturbation of the pathway in the liver may be a 
major cause of the hepatomegaly and hepatocarcino- 
genesis these proliferators induce. 
Acknowledgements: We acknowledge Professor Michihiro Kasahara 
(Teikyo University, Tokyo) for his advice on histidine phosphoryla- 
tion. We are grateful to Miss A. Kuribayashi for her technical assis- 
tance with the identification of the phosphorylated amino acid. 
REFERENCES 
111 
121 
[31 
[41 
PI 
Lazarow, P.B. and Fujiki, Y. (1985) Annu. Rev. Cell Biol. 1, 
489-530. 
Fahimi, H.D. and Sies, H. (1987) Peroxisomes in Biology and 
Medicines, Springer-Verlag. Berlin. 
Lock, E.A., Mitchell, A.M. and Elcombe, C.R. (1989) Annu. 
Rev. Pharmacol. Toxicol. 29, 145-163. 
Issemann, I. and Green, S. (1990) Nature 347, 645-650. 
Tugwood, J.D., Issemann, I., Anderson, R.G., Bundell, K.R.. 
McPheat. W.L. and Green, S. (1992) EMBO J. 11, 433439. 
78 
Volume 3 19, number 1.2 FEBS LETTERS March 1993 
[6] Osumi, T. and Fujiki, Y. (1990) BioEssays 12, 217-222. 
[7] Erdmann, R., Wiebel, F.F., Flessan, A., Rytka, J., Beyer, A., 
Frohlich, K.-U., Kunau, W.-H. (1991) Cell 64, 499-510. 
[8] Tsukamoto, T., Miura, S. and Fujiki, Y. (1991) Nature 350, 
77-81. 
[9] Shinozawa, N., Tsukamoto, T., Suzuki, Y., Orii, T., Shirayoshi, 
Y.. Mori, T. and Fujiki, Y. (1992) Science 255, 1132-l 134. 
[IO] Reddy, J.K. and Rao, M.S. (1986) Trends Pharmacol. Sci. 7, 
438443. 
[11] Motojima, K. and Goto, S. (1992) FEBS Lett. 308, 207-210. 
[12] Motojima, K., Goto, S. and Imanaka, T. (1992) B&hem. Bio- 
phys. Res. Commun. 188, 799-806. 
[13] Hubbard, A.L., Wall, D.A. and Ma, A. (1983) J. Cell Biol. 96, 
217-229. 
[14] McCune, B.K. and Earp, H.S. (1989) J. Biol. Chem. 264, 15501- 
15507. 
[15] Wei, Y.-F. and Matthews, H.R. (1991) Methods Enzymol. 200, 
388414. 
[16] Monoz, G. and Marchall, S.H. (1990) Anal. Biochem. 190, 2333 
237. 
[17] Hidaka, H., Inagaki, M., Kawamoto, S. and Sasaki, Y. (1984) 
Biochemistry 23, 50365041. 
[18] Saitoh, M., Naka, M. and Hidaka, H. (1986) B&hem. Biophys. 
Res. Commun. 140, 28&287. 
[19] Weigel, N., Kukuruzinska, M.A., Nakazawa, A., Waygod, E.B. 
and Roseman, S. (1982) J. Biol. Chem. 257, 14477-14491. 
[20] Wylie, D.C., Stock, A., Wong, C.-Y. and Stock, J. (1988) Bio- 
them. Biophys. Res. Commun. 151, 891-896. 
[21] Hedge, A.N. and Das, M.R. (1987) FEBS Lett. 217, 7480. 
[22] Hedge, A.N. and Das, M.R. (1990) Mol. Cell. Biol. 10, 2468- 
2474. 
[23] Huang, J., Wei, Y., Kim, Y., Osterberg. L. and Matthews, H.R. 
(1991) J. Biol. Chem. 266, 9023-9031. 
[24] Huang, Y.K., Kung, H.-F. and Kamata, T. (1990) Proc. Natl. 
Acad. Sci. USA 87, 8008-8012. 
[25] Stock, J.B., Stock, A.M. and Mottonen, J.M. (1990) Nature 344, 
395400. 
[26] Chen, C.-C., Smith, D.L., Bruegger, B.B., Halpem, R.M. and 
Smith, R.A. (1974) Biochemistry 13, 3785-3789. 
79 
